Major Pharmaceuticals carvedilol tablets recalled over nitrosamine impurity above FDA limit
Carvedilol Tablets USP, 12.5 mg, packaged by Major Pharmaceuticals, lot T05693, are recalled nationwide because N-Nitroso Carvedilol Impurity-1 exceeded the FDA-recommended 4.0 ppm limit. 26,628 cartons are affected.
- Product
- CARVEDILOL — CARVEDILOL (CARVEDILOL)
- Category
- Drug
- Distribution
- Distributed nationwide